Global Quantitative Structure-Activity Relationship (QSAR) Market Research Report 2023

Publication ID:

PB504232084

Publication Date:

May 12, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

IT Services [2]

Computing & Electronics [3]

Description:

QSAR is a computational modeling method used to determine relationships between structural properties and biological activities of chemical compounds. The drug discovery and development, along with studying the potential therapeutic applications of the drug, is a complicated, expensive, and time-consuming process. Pharmaceutical and biopharmaceutical companies are adopting various computational methodologies such as QSAR to increase the efficiency of this entire process. In stages from hit identification to lead optimization, techniques such as ligand or structure-based virtual screening are widely being used by various pharmaceutical companies. With the help of modeling, existing data can be leveraged to gain insights into product safety and effectiveness. Owing to the efficiency of computational methods, the Foof and Drug Administration (FDA) and European Medicines Agency (EMA) have incorporated drug modeling to achieve efficient drug development. In addition, in silico (computer-aided) designs are being utilized to expedite and accomplish the process of hit identification; optimize the distribution, absorption, and metabolism of compounds; and draw toxicity profile to avoid safety issues.
Highlights
The global Quantitative Structure-Activity Relationship (QSAR) market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Quantitative Structure-Activity Relationship (QSAR) is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Quantitative Structure-Activity Relationship (QSAR) is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Quantitative Structure-Activity Relationship (QSAR) in Pharmaceuticals is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Quantitative Structure-Activity Relationship (QSAR) include Protoqsar Sl, Intertek Group Plc, Bibra Toxicology Advice And Consulting Ltd, Covance Inc. (Labcorp), Latham Biopharm Group, Nsf International, Creative Biolabs, Qsar Lab and DassaultSystemes, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Quantitative Structure-Activity Relationship (QSAR), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Quantitative Structure-Activity Relationship (QSAR).
The Quantitative Structure-Activity Relationship (QSAR) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Quantitative Structure-Activity Relationship (QSAR) market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Quantitative Structure-Activity Relationship (QSAR) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Protoqsar Sl
Intertek Group Plc
Bibra Toxicology Advice And Consulting Ltd
Covance Inc. (Labcorp)
Latham Biopharm Group
Nsf International
Creative Biolabs
Qsar Lab
DassaultSystemes
Segment by Type
Fragment Based
3D-QSAR
Chemical Descriptor Based
Segment by Application
Pharmaceuticals
Cosmetics
Environmental
Food and Beverages
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Quantitative Structure-Activity Relationship (QSAR) companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Quantitative Structure-Activity Relationship (QSAR) Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Fragment Based
1.2.3 3D-QSAR
1.2.4 Chemical Descriptor Based
1.3 Market by Application
1.3.1 Global Quantitative Structure-Activity Relationship (QSAR) Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Pharmaceuticals
1.3.3 Cosmetics
1.3.4 Environmental
1.3.5 Food and Beverages
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Quantitative Structure-Activity Relationship (QSAR) Market Perspective (2018-2029)
2.2 Quantitative Structure-Activity Relationship (QSAR) Growth Trends by Region
2.2.1 Global Quantitative Structure-Activity Relationship (QSAR) Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Quantitative Structure-Activity Relationship (QSAR) Historic Market Size by Region (2018-2023)
2.2.3 Quantitative Structure-Activity Relationship (QSAR) Forecasted Market Size by Region (2024-2029)
2.3 Quantitative Structure-Activity Relationship (QSAR) Market Dynamics
2.3.1 Quantitative Structure-Activity Relationship (QSAR) Industry Trends
2.3.2 Quantitative Structure-Activity Relationship (QSAR) Market Drivers
2.3.3 Quantitative Structure-Activity Relationship (QSAR) Market Challenges
2.3.4 Quantitative Structure-Activity Relationship (QSAR) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Quantitative Structure-Activity Relationship (QSAR) Players by Revenue
3.1.1 Global Top Quantitative Structure-Activity Relationship (QSAR) Players by Revenue (2018-2023)
3.1.2 Global Quantitative Structure-Activity Relationship (QSAR) Revenue Market Share by Players (2018-2023)
3.2 Global Quantitative Structure-Activity Relationship (QSAR) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Quantitative Structure-Activity Relationship (QSAR) Revenue
3.4 Global Quantitative Structure-Activity Relationship (QSAR) Market Concentration Ratio
3.4.1 Global Quantitative Structure-Activity Relationship (QSAR) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Quantitative Structure-Activity Relationship (QSAR) Revenue in 2022
3.5 Quantitative Structure-Activity Relationship (QSAR) Key Players Head office and Area Served
3.6 Key Players Quantitative Structure-Activity Relationship (QSAR) Product Solution and Service
3.7 Date of Enter into Quantitative Structure-Activity Relationship (QSAR) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Quantitative Structure-Activity Relationship (QSAR) Breakdown Data by Type
4.1 Global Quantitative Structure-Activity Relationship (QSAR) Historic Market Size by Type (2018-2023)
4.2 Global Quantitative Structure-Activity Relationship (QSAR) Forecasted Market Size by Type (2024-2029)
5 Quantitative Structure-Activity Relationship (QSAR) Breakdown Data by Application
5.1 Global Quantitative Structure-Activity Relationship (QSAR) Historic Market Size by Application (2018-2023)
5.2 Global Quantitative Structure-Activity Relationship (QSAR) Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Quantitative Structure-Activity Relationship (QSAR) Market Size (2018-2029)
6.2 North America Quantitative Structure-Activity Relationship (QSAR) Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Quantitative Structure-Activity Relationship (QSAR) Market Size by Country (2018-2023)
6.4 North America Quantitative Structure-Activity Relationship (QSAR) Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Quantitative Structure-Activity Relationship (QSAR) Market Size (2018-2029)
7.2 Europe Quantitative Structure-Activity Relationship (QSAR) Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Quantitative Structure-Activity Relationship (QSAR) Market Size by Country (2018-2023)
7.4 Europe Quantitative Structure-Activity Relationship (QSAR) Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Quantitative Structure-Activity Relationship (QSAR) Market Size (2018-2029)
8.2 Asia-Pacific Quantitative Structure-Activity Relationship (QSAR) Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Quantitative Structure-Activity Relationship (QSAR) Market Size by Region (2018-2023)
8.4 Asia-Pacific Quantitative Structure-Activity Relationship (QSAR) Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Quantitative Structure-Activity Relationship (QSAR) Market Size (2018-2029)
9.2 Latin America Quantitative Structure-Activity Relationship (QSAR) Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Quantitative Structure-Activity Relationship (QSAR) Market Size by Country (2018-2023)
9.4 Latin America Quantitative Structure-Activity Relationship (QSAR) Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Quantitative Structure-Activity Relationship (QSAR) Market Size (2018-2029)
10.2 Middle East & Africa Quantitative Structure-Activity Relationship (QSAR) Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Quantitative Structure-Activity Relationship (QSAR) Market Size by Country (2018-2023)
10.4 Middle East & Africa Quantitative Structure-Activity Relationship (QSAR) Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Protoqsar Sl
11.1.1 Protoqsar Sl Company Detail
11.1.2 Protoqsar Sl Business Overview
11.1.3 Protoqsar Sl Quantitative Structure-Activity Relationship (QSAR) Introduction
11.1.4 Protoqsar Sl Revenue in Quantitative Structure-Activity Relationship (QSAR) Business (2018-2023)
11.1.5 Protoqsar Sl Recent Development
11.2 Intertek Group Plc
11.2.1 Intertek Group Plc Company Detail
11.2.2 Intertek Group Plc Business Overview
11.2.3 Intertek Group Plc Quantitative Structure-Activity Relationship (QSAR) Introduction
11.2.4 Intertek Group Plc Revenue in Quantitative Structure-Activity Relationship (QSAR) Business (2018-2023)
11.2.5 Intertek Group Plc Recent Development
11.3 Bibra Toxicology Advice And Consulting Ltd
11.3.1 Bibra Toxicology Advice And Consulting Ltd Company Detail
11.3.2 Bibra Toxicology Advice And Consulting Ltd Business Overview
11.3.3 Bibra Toxicology Advice And Consulting Ltd Quantitative Structure-Activity Relationship (QSAR) Introduction
11.3.4 Bibra Toxicology Advice And Consulting Ltd Revenue in Quantitative Structure-Activity Relationship (QSAR) Business (2018-2023)
11.3.5 Bibra Toxicology Advice And Consulting Ltd Recent Development
11.4 Covance Inc. (Labcorp)
11.4.1 Covance Inc. (Labcorp) Company Detail
11.4.2 Covance Inc. (Labcorp) Business Overview
11.4.3 Covance Inc. (Labcorp) Quantitative Structure-Activity Relationship (QSAR) Introduction
11.4.4 Covance Inc. (Labcorp) Revenue in Quantitative Structure-Activity Relationship (QSAR) Business (2018-2023)
11.4.5 Covance Inc. (Labcorp) Recent Development
11.5 Latham Biopharm Group
11.5.1 Latham Biopharm Group Company Detail
11.5.2 Latham Biopharm Group Business Overview
11.5.3 Latham Biopharm Group Quantitative Structure-Activity Relationship (QSAR) Introduction
11.5.4 Latham Biopharm Group Revenue in Quantitative Structure-Activity Relationship (QSAR) Business (2018-2023)
11.5.5 Latham Biopharm Group Recent Development
11.6 Nsf International
11.6.1 Nsf International Company Detail
11.6.2 Nsf International Business Overview
11.6.3 Nsf International Quantitative Structure-Activity Relationship (QSAR) Introduction
11.6.4 Nsf International Revenue in Quantitative Structure-Activity Relationship (QSAR) Business (2018-2023)
11.6.5 Nsf International Recent Development
11.7 Creative Biolabs
11.7.1 Creative Biolabs Company Detail
11.7.2 Creative Biolabs Business Overview
11.7.3 Creative Biolabs Quantitative Structure-Activity Relationship (QSAR) Introduction
11.7.4 Creative Biolabs Revenue in Quantitative Structure-Activity Relationship (QSAR) Business (2018-2023)
11.7.5 Creative Biolabs Recent Development
11.8 Qsar Lab
11.8.1 Qsar Lab Company Detail
11.8.2 Qsar Lab Business Overview
11.8.3 Qsar Lab Quantitative Structure-Activity Relationship (QSAR) Introduction
11.8.4 Qsar Lab Revenue in Quantitative Structure-Activity Relationship (QSAR) Business (2018-2023)
11.8.5 Qsar Lab Recent Development
11.9 DassaultSystemes
11.9.1 DassaultSystemes Company Detail
11.9.2 DassaultSystemes Business Overview
11.9.3 DassaultSystemes Quantitative Structure-Activity Relationship (QSAR) Introduction
11.9.4 DassaultSystemes Revenue in Quantitative Structure-Activity Relationship (QSAR) Business (2018-2023)
11.9.5 DassaultSystemes Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Protoqsar Sl
Intertek Group Plc
Bibra Toxicology Advice And Consulting Ltd
Covance Inc. (Labcorp)
Latham Biopharm Group
Nsf International
Creative Biolabs
Qsar Lab
DassaultSystemes

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂